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SAINT LOUIS UNIVERSITY SCHOOL OF LAW

BALANCING COMMUNAL GOODS AND PERSONAL PRIVACY
UNDER A NATIONAL HEALTH INFORMATIONAL PRIVACY RULE

LAWRENCE O. GOSTIN*, JAMES G. HODGE, JR.**
AND MIRA S. BURGHARDT***
Every single health care professional, every insurance agent, every researcher,
every member of an IRB, every public health official, every pharmacist . . . –
every single person who comes in contact with health care records must
understand why its important to keep them safe, how they can keep them safe,
[and] what will happen to them if they do not keep them safe.1

INTRODUCTION
On April 14, 2001, President George W. Bush approved the Standards for
Privacy of Individually Identifiable Health Information (hereinafter referred to
as “health data privacy rule”). These regulations, which represent the first
systematic national privacy protections of health information,2 flow from a
Congressional mandate in the Health Insurance Portability and Accountability
Act of 1996 (HIPAA).3 HIPAA required that health information privacy
protections be implemented either through federal legislation or administrative

* J.D., L.L.D. (Hon); Professor of Law, Georgetown University Law Center; Professor, Johns
Hopkins Bloomberg School of Public Health; Director, Center for Law and the Public’s Health at
Georgetown and Johns Hopkins Universities. The authors would like to acknowledge the
research assistance of Auburn Daily, J.D. Candidate, Georgetown University Law Center, 2003.
** J.D., L.L.M.; Adjunct Professor of Law, Georgetown University Law Center; Assistant
Scientist, Johns Hopkins Bloomberg School of Public Health; Project Director, Center for Law
and the Public’s Health at Georgetown and Johns Hopkins Universities.
*** J.D. Candidate, 2002, Georgetown University Law Center; Senior Research Assistant, Center
for Law and the Public’s Health at Georgetown and Johns Hopkins Universities.
1. Donna E. Shalala, Health Care Information and Privacy, 8 HEALTH MATRIX 223, 231
(1998) (emphasis added).
2. See Press Release, President George W. Bush (Apr. 12, 2001), available at
http://www.whitehouse.gov/news/releases/2001/04/20010412-1.html (last visited Oct. 19, 2001);
Press Release, Secretary Tommy G. Thompson, Statement by HHS Secretary Tommy G.
Thompson Regarding the Patient Privacy Rule (Apr. 12, 2001), available at
http://www.hhs.gov/news/press/2001pres/20010412.html (last visited Jan. 7, 2001) [hereinafter
Press Release, Secretary Thompson].
3. Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110
Stat. 1936 (1996) [hereinafter HIPAA].
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regulation by the Department of Health and Human Services (HHS). The
regulations protect the privacy of individually-identifiable health records in
any form (including electronic, paper and oral) through disclosure and use
limitations, fair information practices, and privacy and security policies that
apply to “covered entities” (meaning health providers, health insurance plans
and health care clearinghouses) and their business associates.
Privacy safeguards are needed because of the personal nature of health data
and the rapid shift from paper to electronic records. The harms of
unauthorized disclosures of health information are well rehearsed. Health
information used by health providers, insurers and data processors can include
intimate details about the patient’s mental and physical health as well as social
Unwarranted
behaviors, personal relationships and financial status.4
disclosures of this information may lead to societal stigmatization and
discrimination. Unauthorized disclosures can also lead to a loss of patient trust
in medical providers, resulting in a reluctance to seek medical treatment for
some conditions or failure to disclose important information to health
professionals.5
Privacy concerns are compounded by the shift from paper-based to
electronic medical record-keeping in the past two decades. Health information
is increasingly accessed, used, disclosed and stored in electronic format. This
does not necessarily mean health data are less secure, as electronic systems are
in many ways safer than manual systems. Nevertheless, electronic data can be
accessed in greater quantities and manipulated in ways that are virtually
impossible for manual systems. Thus, while significant benefits may flow
from the electronic health information infrastructure, the potential to disclose
or reveal sensitive health data has raised individual fears of privacy violations.
In one recent survey, over 80% of the public respondents felt they had “lost all
control” over their personal information.6
Patients concerned about a lack of privacy were unlikely to be comforted
by federal protections before the promulgation of the HIPAA rule. Prior to the
rule, there had never been systematic national health information protection.
While most states have privacy safeguards, they are so variable and incoherent
that they are widely regarded as inadequate. Congress’s grant of authority to
HHS to develop privacy standards offered the promise of a considered and
comprehensive regulatory solution to address the concerns of consumers and
privacy advocates. The standards endeavor to protect patient privacy by
limiting disclosures of individually-identifiable medical information (or

4. See Lawrence O. Gostin, Health Information Privacy, 80 CORNELL L. REV. 451, 490
(1995) [hereinafter Gostin, Health Information Privacy].
5. See id. at 490-91.
6. Id. at 454. See also Harris Equifax, Health Information Privacy Survey (1993), available
at http://www.epic.org/privacy/medical/polls.html (last visited Oct. 19, 2001).

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

2002]

BALANCING COMMUNAL GOODS AND PERSONAL PRIVACY

7

“protected health information”(PHI)). Disclosure and use of PHI can only
occur upon patient consent. The regulations also implement fair information
practices, which have long been a feature of existing federal laws.7 Fair
information practices allow patients to (1) inspect and amend their records, (2)
receive notice of covered entities’ privacy practices and potential uses and
disclosures of health information, and (3) request confidential communications
and an accounting of actual disclosures.
Through the regulations, HHS attempts to protect individual privacy while
recognizing legitimate needs for such data to process health claims and deliver
medical care as well as provide for communal goods (including public health
and health research). Concerning uses and disclosures of health data, HHS
carves out several important exceptions to the consent requirements:
1) Law enforcement. Law enforcement officials may receive information
from covered entities without consent pursuant to a court order, subpoena or
other legal order.
2) Judicial and administrative proceedings. A covered entity may disclose
PHI in a judicial or administrative proceeding without the individual’s consent
in response to an order of the court or administrative tribunal or in certain
circumstances, a subpoena or discovery request.
3) Commercial marketing. Covered entities may use or disclose personal
health information for face-to-face commercial marketing to individuals or
regarding products or services of nominal value.
4) Parents of unemancipated minors. Parents are recognized as personal
representatives of unemancipated minors. While the rule places certain
restrictions on parent’s access to the child’s medical record, HHS
acknowledges that the Bush Administration is likely to relax those limitations.8
5) Family members, friends, and caretakers (“significant others”) of adults
and emancipated minors. Covered entities may disclose limited health
information of an adult or emancipated minor without consent to a relative,
personal friend or designated person in the case of an emergency or in the
course of basic care-taking duties.
6) Public health. PHI can be disclosed for numerous public health
purposes without consent, including to (a) prevent or control disease, injury or
disability, (b) report child abuse or neglect, (c) report relevant information to
the Food and Drug Administration, and (d) report to an employer conducting
medical surveillance in the workplace if the employee is notified.
7) Health research. A covered entity can use or disclose PHI for research
without consent if it obtains a waiver from an Institutional Review Board
(IRB) or a privacy board according to a series of considerations.9
7. See infra Part II.D. for a discussion of fair information practices.
8. See Press Release, Secretary Thompson, supra note 2.
9. See generally 45 C.F.R. § 164.512 (2001).

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

8

SAINT LOUIS UNIVERSITY LAW JOURNAL

[Vol. 46:5

Many of these provisions leave significant gaps in privacy protection.
HHS admits that the rule only sets a “floor” of protection that “balance[s] the
needs of the individual with the needs of society.”10 However, the rule
contains many flaws as a base-line standard, promoting inappropriate tradeoffs between the public welfare and individual privacy. The rule inadequately
protects privacy in certain contexts, including the consent requirements for use
and disclosure of PHI for health care purposes and some fair information
practices provisions. In contrast, the rule sometimes fails to assure that
information can be used when necessary for significant communal benefits or
requires substantial burdens on the health care industry without providing
meaningful protection for patients.
In Part I, we examine how the threat to personal privacy from the
developing electronic health information infrastructure necessitates
comprehensive national health information privacy regulations. Attempts by
federal and state officials to regulate the use and disclosure of personal health
information prior to the new standard have been inadequate because existing
legal provisions allow multiple exceptions to privacy prohibitions.
We examine and analyze the framework of HHS’s effort to protect
individually identifiable electronic health information in Part II. Patients
obtain several new rights and protections related to their individually
identifiable health information.
However, throughout the standard,
inappropriate trade-offs between individual privacy and communal goods
compromise the strides made for protecting personal health information
privacy. A brief conclusion follows.
I. THE ELECTRONIC HEALTH INFORMATION INFRASTRUCTURE AND PERSONAL
PRIVACY
A.

Health Data in the Electronic Health Information Infrastructure

Protecting the privacy of identifiable health information was one of the key
priorities of Congress in enacting the Health Insurance Portability and
Accountability Act of 1996. One of the main reasons that Congress desired
privacy protection was its concern about the proliferation of electronic health
information. During the mid-1980’s, fundamental shifts in the organization,
delivery and financing of health care services led to the development of more

10. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462 (Dec. 28, 2000). For electronic copies of the health data privacy rule, including the
background materials and comments published in the federal register, see the Department of
Health and Human Services’ website, available at http://aspe.hhs.gov/admnsimp (last visited Jan.
7, 2002) or http://www.hhs.gov/ocr/hipaa (last visited Jan. 7, 2002).
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sophisticated health information systems.11 Today, individual patient medical
records are increasingly stored in electronic databases by government and
private medical providers. The goal that fueled these changes, as expressed by
the Institute of Medicine and others, was that patient medical records should be
recorded in every health care setting and accessed widely among health care
professionals.12 These changes are transforming how health information is
acquired, used, disclosed and stored in the modern health care system.
Many advantages exist to the systemic collection and use of electronic
health data. More accurate and accessible data allow consumers to make more
informed decisions about health plans, providers, diagnoses, products and
treatments. Clinical care is improved through faster and more accurate
diagnoses,13 increased checks on medical procedures,14 prevention of adverse
drug events15 and the dissemination of expert medical information in areas
traditionally under-served through telemedicine and other techniques. Medical
research on the causes of disease and injuries and health services research
concerning the quality and cost-effectiveness of health care services are
improved through increased access to information and more accurate
information. Public health surveillance of injuries and diseases in the
population is facilitated.16 Finally, electronic security tools including personal
access codes, encryption programs17 and audit trails18 can more efficiently
monitor health care fraud and abuse19 and protect data from unauthorized uses
and disclosures.
Along with these benefits, however, come significant costs. The
computerization of health data raises significant privacy concerns. Health care
11. See NATIONAL RESEARCH COUNCIL, COMMITTEE ON MAINTAINING PRIVACY AND
SECURITY IN HEALTH CARE APPLICATIONS OF THE NATIONAL INFORMATION INFRASTRUCTURE,
FOR THE RECORD: PROTECTING ELECTRONIC HEALTH INFORMATION 21-22 (1997); Lawrence O.
Gostin, Personal Privacy in the Health Care System: Employer-Sponsored Insurance, Managed
Care, and Integrated Delivery Systems, 7 KENNEDY INST. ETHICS J. 361, 364 (1997).
12. See Gostin, Health Information Privacy, supra note 4, at 452-53.
13. See Dereck L. Hunt et al., Effects of Computer-Based Clinical Decision Support Systems
on Physician Performance and Patient Outcomes, 280 JAMA 1339, 1342 (1998).
14. See David W. Bates et al., Effect of Computerized Physician Order Entry and a Team
Intervention on Prevention of Serious Medication Errors, 280 JAMA 1311, 1315 (1998).
15. See Robert A. Raschke et al., A Computer Alert System to Prevent Injury from Adverse
Drug Events, 280 JAMA 1317, 1320 (1998).
16. See Lawrence O. Gostin et al., The Public Health Information Infrastructure, 275 JAMA
1921, 1921 (1996) [hereinafter Gostin et al., Genetic Privacy and the Law]. See also Antoine
Flahault et al., FluNet as a Tool for Global Monitoring of Influenza on the Web, 280 JAMA 1330
(1998).
17. See Elizabeth Corcoran, Breakthrough Possible in Battle over Encryption Technology,
WASH. POST, July 12, 1998, at A8.
18. See NATIONAL RESEARCH COUNCIL, COMPUTERS AT RISK: SAFE COMPUTING IN THE
INFORMATION AGE 88 (1991).
19. See Gostin, Health Information Privacy, supra note 4, at 481.
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data about individuals are among the most sensitive types of personal
information. These records contain large amounts of personal information
which can be used to create a profile of an individual, including 1)
demographic information, such as age, sex, race, marital status, children and
occupation; 2) financial information, such as employment status, income and
methods of payment; 3) medical information about diagnoses, treatments,
disabilities, end-of-life decisions and disease histories of the individual and
family members; 4) genomic information, such as diagnostic tests for carrier
traits and genetically-related diseases; 5) personal identifiers other than name,
including Social Security number, addresses and phone numbers; and 6)
information about why treatment is sought, such as being the victim of a
violent crime, firearm injury or the at-fault party in an auto accident.20
In a society which strongly values individual autonomy and decisionmaking, protecting the privacy of personally-identifiable health data is critical.
Insufficient protections of health care information lead to unauthorized
disclosures which may subject individuals to social stigma and discrimination
by insurance companies, health care professionals and institutions, and
employers.21 Patients have a reasonable expectation of privacy in their
personal affairs provided the exercise of these interests does not harm others.22
Respecting personal privacy requires that individuals maintain some degree of
control over their personal information. In addition, protecting the privacy of
individually-identifiable health information is often important to achieve
benefits to the population, such as public health surveillance and longitudinal
health research. As we (and others) have stated, protecting health information
privacy (for instance, by providing individuals some control over their health
data without severely restricting warranted uses of the data) directly improves
the quality of health care and public health data (for instance, by encouraging
individuals to fully utilize health services and cooperate with health
agencies).23

20. See Lawrence Gostin, Health Care Information and the Protection of Personal Privacy:
Ethical and Legal Considerations, 127 ANNALS INTERNAL MED. 683, 684-85 (1997).
21. See, e.g., Lawrence O. Gostin & James G. Hodge, Jr., The “Names Debate”: The Case
for National HIV Reporting in the United States, 61 ALB. L. REV. 679, 724 (1998).
22. TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS 126
(4th ed. 1994).
23. James G. Hodge, Jr. et al., Legal Issues Concerning Electronic Health Information, 282
JAMA 1466, 1470 (1999).
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The Inadequacy of Existing Legal Protections

Personal privacy can be safeguarded in several ways, including through the
privacy policies of data holders in the public and private sectors.24 The law,
however, is uniquely important because it sets clear standards that are
enforceable through courts and administrative bodies. Legal safeguards may
be expressed through federal or state constitutional protections of health
information privacy, legislation or case law. Despite the law’s potential to
protect privacy, existing legal safeguards are inadequate, fragmented and
inconsistent. There exist major gaps in legal protection of privacy and
significant theoretical problems with the structure of privacy protection.
1.

Constitutional Right to Privacy

The Supreme Court has not articulated a clear, strong standard for a
constitutional right to informational privacy outside the Fourth Amendment.25
Judicial recognition of a constitutional right to informational privacy is
particularly important because the government is a primary collector and
disseminator of health information. A constitutional right would help shield
individuals from unauthorized government acquisition or disclosure of
personal information.
The Constitution does not expressly provide a right to informational
privacy.26 The judiciary, however, has recognized a limited right to
informational privacy as a liberty interest within the Fifth and Fourteenth
Amendments. In Whalen v. Roe,27 the United States Supreme Court examined
24. The law is merely one tool to improve individual privacy protections. Internal privacy
policies of health care providers, data processors and other private sector entities, which acquire,
use and disclose identifiable health data can greatly impact individual expectations of the privacy
of their health information. The same can be said for voluntarily-executed policies of
governmental holders of data, including public health agencies, researchers, universities and
academic centers, and other commissions or agencies. Adherence to ethical principles and human
rights documents in support of the privacy of individual health data may also lead to greater
privacy protections. Ultimately, however, where government and the private sector fail to
administer sufficient privacy protections, the law may guide, if not require, such protections.
25. See generally, Seth F. Kreimer, Sunlight, Secrets, and Scarlet Letters: The Tension
Between Privacy and Disclosure in Constitutional Law, 140 U. PA. L. REV. 1 (1991); Richard C.
Turkington, Legacy of the Warren and Brandeis Article: The Emerging Unencumbered
Constitutional Right to Informational Privacy, 10 N. ILL. U. L. REV. 479 (1990); Francis S.
Chlapowski, Note, The Constitutional Protection of Informational Privacy, 71 B.U. L. REV. 133
(1991).
26. See Gostin, Health Information Privacy, supra note 4, at 495.
27. 429 U.S. 589 (1977); see also Nixon v. Adm’r of Gen. Servs., 433 U.S. 425, 465 (1977).
In Nixon, the court held that while the President has
a legitimate expectation of privacy in his personal communications . . . the
constitutionality of the Act must be viewed in the context of the limited intrusion of the
screening process, of appellant’s status as a public figure, of his lack of any expectation of
privacy in the overwhelming majority of the materials, of the important public interest in
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whether the constitutional right to privacy encompasses the collection, storage
and dissemination of health information in government data banks
(specifically, a New York public health database containing pharmaceutical
records). While the Court acknowledged a “threat to privacy implicit in the
accumulation of vast amounts of personal information in computerized data
banks or other massive government files,”28 it failed to tailor a constitutional
remedy to meet this threat. Justice Stevens, writing for a unanimous Court,
simply recognized that “in some circumstances” the duty to avoid unwarranted
disclosures “arguably has its roots in the Constitution.”29 Provided the state
has adequate standards and procedures for protecting the privacy of sensitive
medical information, the Court found no privacy violation.30 Whalen has been
subsequently interpreted as affording a tightly circumscribed right to
informational privacy.
In general, courts have employed a flexible test balancing the government
invasion of privacy against the strength of the government interest.31 Where
the government can articulate a valid societal purpose and employs reasonable
security measures, traditional governmental activities of information collection
are deemed not to infringe upon constitutional informational privacy rights.
Any right to privacy under the federal or state constitutions32 is, of course,
limited to state action. Thus, collection and use of health data by private or
quasi-private health data organizations, health plans researchers and insurers is
constitutionally unprotected.

the preservation of the material, and of the virtual impossibility of segregating the small
quantity of private materials without comprehensive screening . . . the appellant’s privacy
claim is without merit.
Id.
28. Whalen, 429 U.S. at 605.
29. Id.
30. Id.
31. For example, the court in United States v. Westinghouse Electric Corp. held that the
National Institute of Occupational Safety and Health was entitled to receive the medical records
of private employees exposed to toxic substance, subject to their informed consent. 638 F.2d
570, 578 (3d Cir. 1980). The court enunciated five factors to be balanced in determining the
scope of the constitutional right to informational privacy: (1) the type of record and the
information it contains, (2) the potential for harm in any unauthorized disclosure, (3) “the injury
from disclosure to the relationship in which the record was generated,” (4) “the adequacy of
safeguards to prevent unauthorized disclosure,” and (5) “the degree of need for access”—
meaning, a recognizable public interest. Id.
32. See, e.g., Rasmussen v. S. Fla. Blood Serv., Inc., 500 So. 2d 533 (Fla. 1987). Since the
1970s, more than a dozen states have adopted constitutional amendments designed to protect a
variety of privacy interests, including limitations on access to personal information. See Gostin,
Health Information Privacy, supra note 4, at 498.
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Common Law Protections

Most states recognize via common and statutory law the legal duties of
confidentiality of certain health care professionals (including physicians,
nurses and lab technicians) not to disclose health information. Yet, these
duties are not absolute: “Disclosures without individual consent may lawfully
be made to [1] protect third parties from identifiable harm, [2] to report
information for public health purposes as required by state law, or [3]
sometimes in cases of medical emergency. Unwarranted disclosures, however,
may subject responsible parties to civil liability . . . .”33
Although a traditional construct of privacy protections and a forerunner of
modern privacy theory, the duty of confidentiality is antiquated.
Confidentiality is predicated on the existence of a physician/patient
relationship. However, modern data collection is based only in small part on
this relationship. Health records contain a substantial amount of information
gathered from numerous primary and secondary sources: laboratories,
pharmacies, schools, public health officials, researchers, insurers and other
individuals and institutions. Paper or electronic patient health records are not
merely kept in the office of private physicians or health plans, but also by
government agencies, regional health database organizations and information
brokers. The duty of confidentiality arising at the point of clinical care or
research simply does not convey a right to confidentiality in all these important
contexts.
3.

Existing Legislative and Administrative Protections

Federal and state legislatures and executive agencies have enacted and
considered a growing number of statutes and regulations to protect privacy.34
The federal government has previously enacted several statutes and regulations
to protect privacy of health information. The Privacy Act of 197435 requires
federal agencies to utilize fair information practices regarding the collection,
use or dissemination of systematized records, including health data. The
Freedom of Information Act (FOIA) of 196636 requires the federal government
to disseminate various information but exempts several categories of records,
including personally-identifiable health information. Other federal regulations
protect health information privacy relating to the treatment of persons for drug

33. Lawrence O. Gostin & James G. Hodge, Jr., Genetic Privacy and the Law: An End to
Genetics Exceptionalism, 40 JURIMETRICS 21, 46 (1999) [hereinafter Gostin & Hodge, Genetic
Privacy and the Law]. See also McCormick v. England, 494 S.E.2d 431, 439 (S.C. Ct. App.
1997); Gostin, Health Information Privacy, supra note 4, at 508-11.
34. For a discussion of various regulations enacted to protect privacy, see Gostin, Health
Information Privacy, supra note 4, at 499-508.
35. 5 U.S.C. § 552a (2000).
36. 5 U.S.C. § 552 (b)(1)-(3) & (6) (1988).

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

14

SAINT LOUIS UNIVERSITY LAW JOURNAL

[Vol. 46:5

or alcohol dependency in federally-funded facilities37 and the administration of
human subject research.38
Most states have passed privacy statutes that mimic the Federal Privacy
39
Act and FOIA,40 and thus apply only to state collections of data. A few states
have enacted comprehensive medical information privacy acts.41 These laws
provide broad protections of health information acquired, collected, used or
disclosed within the state. States have also passed disease-specific privacy
laws which set forth stringent privacy and security protections for certain types
of information, including medical information concerning one’s HIV status42
or other sexually-transmitted diseases,43 genetic information,44 information
utilized in medical research (such as state cancer registries) or public health
information.45
Though existing federal and state privacy statutes and regulations are
meaningful and serve valuable ends, they share several weaknesses: (1) like
constitutional privacy protections, most statutes apply primarily to government
collections, uses or disclosures of health information, and thus often do not
confer protections to health information in the private sector; (2) they fail to
address the new challenges to individual privacy arising from the automation
of medical records; (3) they collectively represent a patchwork effort to
address the privacy and security of specific health information or information
held by specific entities, and thus do not comprehensively protect health
information; (4) some kinds of data are treated as super-confidential (for
instance, HIV/AIDS), while other data are virtually unprotected, leading to
inconsistencies and unfairness; (5) they do not effectively balance competing
individual interests in privacy with the need to use the data for the common
good; and (6) some state laws prohibit disclosures without informed consent,
but list so many exceptions as to swallow the rule. These weaknesses in
existing law require a national approach to privacy protection. The health data
privacy rule provides such a national standard and makes significant strides in
protecting health data. However, the rule shares many of the weaknesses of
existing privacy laws. In some ways, the rule inadequately protects privacy,
37. 42 U.S.C. § 290dd-2 (Supp. V 1994).
38. 45 C.F.R. § 46.111(7) (1993).
39. See, e.g., N.Y. PUB. OFF. LAW §§ 91-99 (McKinney 2001).
40. See, e.g., MISS. CODE ANN. §§ 25-61-1 (1972).
41. See, e.g., CAL. CIV. CODE §§ 56-56.35 (West 1982 & Supp. 2001); WASH. REV. CODE
ANN. §§ 70.02.005-70.02.904 (West 1992 & Supp. 2001).
42. See generally Harold Edgar & Hazel Sandomire, Medical Privacy Issues in the Age of
AIDS: Legislative Options, 16 AM. J.L. & MED. 155 (1990) (examining state legislation dealing
with HIV related problems in medical privacy laws).
43. See Lawrence O. Gostin, The Future of Public Health Law, 12 AM. J.L. & MED. 461,
486 (1986).
44. See, e.g., Gostin & Hodge, Genetic Privacy and the Law, supra note 33, at 47.
45. See Gostin et al., Genetic Privacy and the Law, supra note 16, at 1922.
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while in other ways it fails to assure that data are shared where necessary to
protect the public’s welfare.
II. PROTECTING PERSONAL PRIVACY IN THE NEW STANDARD
The creation of a national health information privacy rule might seem
uncontroversial in light of existing public apprehensions, current gaps in legal
protections and Congress’s commitment to better protecting such data.
However, the health privacy rule was established only after years of struggle
and efforts in the legislative and executive branches. In HIPAA, Congress
created a self-imposed deadline of August 21, 1999 to pass health information
privacy legislation.46 Due in part to the lobbying of the various interest groups
affected by such legislation,47 Congress failed to reach a consensus by the
deadline.48 In default, HIPAA authorized the Secretary of the HHS to issue
privacy regulations if Congress failed to meet the deadline.49 After issuing a
proposed rule in November, 1999,50 HHS received over 50,000 public
comments.51 The final rule was promulgated in December, 2000 at the end of
President Clinton’s term.52 Reflecting President Bush’s promise to reassess
regulations enacted late in his predecessor’s term,53 the comment period was
re-opened and HHS received several thousand additional comments.54 Though
privacy advocates were concerned that the Bush Administration would scale
back or eliminate the rules altogether,55 HHS Secretary Tommy Thompson
46. HIPAA, Pub. L. No. 104-191, § 264(c)(1) (1996).
47. See Amy Goldstein & Robert O’Harrow, Bush will Proceed on Patient Privacy; But
Clinton-Era Rules Likely to be Modified, WASH. POST, Apr. 13, 2001, at A1. This, however, is
nothing new. A 1998 Center for Public Integrity report found that “[t]ime and time again . . .
Congress has put big-money corporate interests ahead of the basic privacy interests of the
American people.” THE CENTER FOR PUBLIC INTEGRITY, NOTHING SACRED: THE POLITICS OF
PRIVACY (1998), available at http://publicintegrity.org/nothing_sacred.html (last visited Nov. 4,
2001).
48. See Press Release, U.S. Department of Health and Human Services, Protecting the
Privacy of Patients’ Health Information (May 9, 2001), available at http://aspe.hhs.gov/
admnsimp/final/pvcfact2.htm [hereinafter HHS Press Release]; Goldstein & O’Harrow, supra
note 47.
49. HIPAA, Pub. L. No. 104-191, § 264(c)(1) (1996).
50. Standards for Privacy of Individually Identifiable Health Information, 64 Fed. Reg.
59,918 (Nov. 13, 1999).
51. See HHS Press Release, supra note 48.
52. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462 (Dec. 28, 2000).
53. See Robert Pear, Bush Accepts Rules to Protect Privacy of Medical Records, N.Y.
TIMES, Apr. 13, 2001, at A1 [hereinafter Pear, Bush Accepts Rules].
54. See Press Release, Secretary Thompson, supra note 2; HHS Press Release, supra note
48.
55. See HEALTH PRIVACY PROJECT, COMMENTS ON THE FINAL FEDERAL STANDARDS FOR
PRIVACY OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION 3 (2001), available at
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announced on April 12, 2001, that the final rule as previously constructed
would go forward, subject to interpretive guidelines developed by HHS.56 The
first of these guidelines was released in July, 2001, with Secretary Thompson
intending to write more.57 The rules take effect for most covered entities on
April 12, 2003, and a year later for small health plans.
Despite its convoluted development, the health data privacy rule provides a
variety of privacy protections for health care consumers.58 The standard
applies to covered entities, such as health care plans, health care
clearinghouses and health providers, along with their business entities.59 HHS
regulates individually-identifiable health information, meaning PHI, derived
from electronic, written and oral communications.60 Uses and disclosures are
subject to consent requirements, so as to prevent harmful sharing of PHI.
These consent requirements are of two broad types: (1) informed consent
provisions relating to the use of health data for transactions that are standard in
the delivery and payment of health care services; and (2) authorization
requirements for disclosures of PHI for non-health care purposes.61
Trade-offs between public good and personal privacy are manifested in
certain exceptions to the authorization requirements for outside disclosures. In
general, PHI may not be disclosed without specific, written authorization,
except: (1) to law enforcement officials; (2) to judicial and administrative
proceedings; (3) for commercial marketing purposes; (4) to parents of
unemancipated minors; (5) to “significant others,” such as family members,

http://www.healthprivacy.org/usr_doc/55009.pdf (last visited Jan. 7, 2001) [hereinafter HEALTH
PRIVACY PROJECT, COMMENTS]; see also Goldstein & O’Harrow, supra note 47; Robert Pear,
White House Plans to Revise New Medical Privacy Rules, N.Y. TIMES, Apr. 8, 2001, at 22.
56. Press Release, Secretary Thompson, supra note 2; see Goldstein & O’Harrow, supra
note 47; Pear, Bush Accepts Rules, supra note 53.
57. Office for Civil Rights, Department of Heath and Human Services, Standards for Privacy
of
Individually
Identifiable
Health
Information,
available
at
http://aspe.hhs.gov/admnsimp/final/pvcguide1.htm (last modified July 6, 2001) [hereinafter
Office for Civil Rights Standards]. See Ceci Connelly, Guidelines on Patient Privacy Rules
Issued; Administration Postpones Action on Parents’ Access to Minors’ Health Records, WASH.
POST, July 7, 2001, at A6; Robert Pear, Administration Clarifies New U.S. Rules Guarding
Privacy of Patients, N. Y. TIMES, July 7, 2001, at A9.
58. To enforce these protections, the Secretary of HHS can investigate complaints and
conduct compliance reviews. See 45 C.F.R. §§ 160.306, 160.308 (2001). Violations of the
standard can lead to civil and criminal penalties up to $250,000 and ten years in prison. See HHS
Press Release, supra note 48. There is no private right of action for individuals to redress
violations.
59. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462, 82,475 (Dec. 28, 2000).
60. Unless the context otherwise requires, all further references to health information refer
only to individually-identifiable data.
61. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
at 82,509.
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close friends, or designated persons, of an adult or emancipated minor, (6) to
an authorized public health authority, and (7) for health research.62
The rule also requires covered entities to develop privacy and security
policies to protect stored health information. Fair information practices set
forth in the rule include a patient’s right to: (1) receive notice of covered
entities’ privacy practices and potential uses and disclosures of health
information;63 (2) review one’s PHI;64 (3) request amendments to one’s PHI;65
and (4) request confidential communications and an accounting of actual
disclosures.66 The regulation generally does not preempt any state law that is
more stringent than the health data privacy rule.67 Thus, states may impose
stricter privacy provisions.
As will be discussed below, the rule endeavors to set a national base-line
of health information privacy protection. Individual privacy, however, is
sometimes under-protected or overprotected within that standard.
A.

The Scope of the Standard

At least two questions arise in the development of a national health
information privacy standard. First, what information should be protected?
Secondly, from whose actions should the information be protected? In the
health data privacy rule, these questions are partially answered by the limits of
HHS’s authority under HIPAA.68
1.

Protected Health Information (PHI)

The regulation explicitly covers health information69 that is individuallyidentifiable.70 Individually-identifiable health information includes any data

62. See generally 45 C.F.R. § 164.512 (2001). In the interest of space and concise
discussion, this Article focuses on the most controversial and significant exemptions to the
consent requirements. However, the rule contains additional exemptions for treatment
emergencies, communication difficulties between patient and provider, legal mandates for
treatment, health oversight activities, decedents, serious threats to health or safety and military
and veteran’s activities. See id. §§ 164.506(a)(3)(i), 164.512.
63. See § 164.520(a).
64. § 164.524(a).
65. § 164.526(a).
66. § 164.528(a).
67. § 160.203(b).
68. For a discussion on the constitutional issues raised because of jurisdictional concerns
related to HIPAA, see A. Craig Eddy, A Critical Analysis of Health and Human Services’
Proposed Health Privacy Regulations in Light of The Health Insurance Privacy and
Accountability Act of 1996, 9 ANNALS HEALTH L. 1, 50-60 (2000).
69. “Health information” is comprehensively defined as data
(1) . . . created or received by a health care provider, health plan, public health authority,
employer, life insurer, school or university, or health care clearinghouse; and (2)
[r]elate[d] to the past, present, or future physical or mental health or condition of an
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that contains unique identifiable characteristics, including a name, social
security or driver’s license number, fingerprint and genetic link.71 Where
health data are truly non-identifiable, there are no individual privacy
implications relating to its access, use or disclosure. Thus, such data require
no privacy protection. Excluding non-identifiable health data (for example,
aggregate statistical data, non-linked data or other data stripped of all
individual identifiers) provides an incentive for data holders to use or deidentify health information to diminish the risk of harmful disclosures and uses
of personal data.72 Under the standard, HHS permits covered entities to assign
codes73 to allow for later re-identification but requires steps be taken to prevent
harmful identifications.74
HHS defines PHI to include all forms of information, including electronic,
oral and paper communications.75 It is impractical to separate protections for
individual; the provision of health care to an individual; or the past, present, or future
payment for the provision of health care to an individual.
§ 160.103.
70. § 164.514 (discussing procedures for de-identification of health information). HHS
defines individually-identifiable health information as health information which “identifies an
individual or with respect to which there is a reasonable basis to believe the information can be
used to identify the individual.” § 164.501. The regulatory definition limits the term to only a
subset of health information, specifically that created or received by health care providers, health
plans, employers or health care clearinghouses. See id.
71. The health data privacy rule outlines two means for determining if health information is
not individually-identifiable (“de-identified”) and thus no longer regulated by the rule. First, an
expert utilizing accepted analytic techniques can conclude that “the risk is very small that the
information could be used, alone or in combination with other reasonably available information”
to identify the subject of the information. § 164.514(b)(1). A second permitted means of deidentification is that the covered entity can remove a comprehensive set of identifiers of the
individual and of relatives, employers and household members of the individual. These
identifiers include names, geographic subdivisions smaller than a state, dates more specific than
years, contact information such as telephone and fax numbers and email addresses, identification
numbers such as social security numbers, account and medical record numbers, license place
numbers and full face photographic images. § 164.514(b)(2)(i).
72. See HEALTH PRIVACY PROJECT, BEST PRINCIPLES FOR HEALTH PRIVACY 15-16 (1999),
available at http://www.healthprivacy.org/usr_doc/33807.pdf (last visited Nov. 4, 2001)
[hereinafter HEALTH PRIVACY PROJECT, BEST PRINCIPLES]; HEALTH PRIVACY PROJECT,
COMMENTS, supra note 55, at 18.
73. Information can be “ostensibly anonymous,” yet linkable to an individual because of
codes frequently utilized by health care organizations, researchers and the government. Concern
is raised about deliberate or accidental disclosures of coded information, not literally protected by
law, where the code is broken or inadequate. Gostin, Health Information Privacy, supra note 4,
at 520.
74. The code must not be derived from or related to information about the individual or able
to be translated so that the individual can be identified. See § 164.514(c)(1). The covered entity
must also not disclose or use the code for other purposes than record identification and cannot
disclose the mechanism for re-identification. See § 164.514(c)(2).
75. § 164.501 (defining “protected health information”).
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paper-based records from electronic or oral-based data. HHS’s attempt to
cover all types of health data, however, is controversial. Congress may not
have granted clear authority to HHS to regulate non-electronic communication
in HIPAA.76 Although HHS maintains it has “ample legal authority” to
regulate non-electronic communications,77 the regulation is structured so that
non-electronic communications are severable by court action from electronic
communications.78 Alternatively, by protecting all health information, the
efficacy of the regulation would be enhanced. Otherwise, a significant amount
of non-electronic health communications would remain unregulated by federal
law. There would be complications in enforcing a national standard applicable
to only some types of health data, depending on how they were communicated
or stored.79
2.

Covered entities.

HHS regulates the actions of “covered entities” that it has authority to
reach under HIPAA. These “covered entities” include health plans, health care

76. Section 264 of HIPAA, which contains the Congressional mandate to HHS to develop
the privacy standard, evolved because of the administrative simplification goals of the statute
related to electronic information exchange. See Standards for Privacy of Individually Identifiable
Health Information, 65 Fed. Reg. 82,462, 82,469 (Dec. 28, 2000); see also Eddy, supra note 68,
at 18. Some commentators have suggested that because section 264 was developed to counteract
negative effects of the administrative simplification provisions, HHS could only regulate privacy
concerns for the narrow set of electronic transactions covered in those provisions. See Eddy,
supra note 68, at 19-20. However, section 264 of HIPAA describes the scope of HHS authority
in terms of regulation of individual rights over “individually identifiable health information,” not
electronic transactions or administrative simplification. Health Insurance Portability and
Accountability Act of 1996, Pub. L. No. 104-191, 110 Stat. 1936, 2033 (1996). The statute states
that if Congress does not meet its deadline, HHS must “at least” develop regulations that address:
“(1) [t]he rights that an individual who is a subject of individually identifiable health information
should have[;] (2) [t]he procedures that should be established for the exercise of such rights[; and]
(3) [t]he uses and disclosures of such information that should be authorized or required.” Id.
This subsection provides the requirements for HHS’s recommendation to Congress when
Congress is considering legislation before its self-imposed deadline has passed. Based on a
cross-reference to 264(b), 264(c) applies these requirements to the regulations that are mandated
if Congress does not meet its deadline. See id. The use of “at least” and the lack of a reference to
the administrative simplification sections or electronic transactions in these detailed requirements
suggests that Congress did not intend to limit HHS to protecting privacy in electronic transactions
only. See HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 5. Nevertheless, ambiguity
remains about HHS’s scope of authority.
77. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. at
82,496.
78. See id. In a successful court challenge to the broad coverage, then the judge could order
that the phrase “regarding non-electronic information” be struck from the regulation while the
standard would remain intact for electronic communications.
79. See HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 6-7.
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clearinghouses and health care providers.80 Health plans, which provide or pay
for the cost of medical care, are covered whether they are private entities (such
as a health insurer or managed care organization) or government organizations
(such as Medicaid, Medicare or the Veterans Administration).81 Health care
providers (meaning physicians, hospitals or clinics) are covered if they
“[transmit] any health information in electronic form in connection with a
transaction covered by [the regulation].”82 Such electronic exchanges can
include billing and fund transfers in addition to health information
communications.
The rule also covers business associates of the covered entities. Business
associates are lawyers, accountants, billing companies and other contractors
whose positions involve the use or disclosure of individually-identifiable
health information.83 Although HHS lacks the authority to directly regulate
business associates, it requires covered entities to obtain “satisfactory
assurance[s] that [their] business associates will appropriately safeguard the
information.”84 Should a covered entity know of a violation and do nothing to
address it, the covered entity may be considered to have violated HIPAA’s
privacy standards.85 While covered entities have protested that this is unfair,
this technique was maintained by HHS in the final rule as a way to regulate the
downstream users and processors of PHI.86
Though the regulations are facially comprehensive in their coverage, not
all persons or entities who regularly use, disclose or store identifiable health
data are covered. For example, the rule does not cover groups such as life
insurance companies or worker’s compensation insurance companies and
programs, even though these entities regularly use personal medical
information.87 Additional protections governing all identifiable health data,

80. § 160.102(a).
81. § 160.103 (defining “health plan”). Employers utilizing employer-sponsored health
plans, governed by ERISA, are not considered covered entities when administering the plan (as
“plan sponsors”). Id. (listing exclusions to the definition of “health plan”). However, the
standard outlines numerous requirements for employer-sponsored health plans, as covered
entities, to disclose PHI to plan sponsors/employers, including an agreement that the sponsor will
not use or disclose the information for employment decisions. § 164.504(f)(1)-(2) (2001).
82. § 160.102(a)(3).
83. See § 160.103.
84. § 164.502(e)(1)(i).
85. See § 164.502(e)(1)(iii).
86. See Lawrence O. Gostin, National Health Information Privacy: Regulations Under the
Health Insurance Portability and Accountability Act, 285 JAMA 3015, 3016 (2001) [hereinafter
Gostin, Regulations under HIPAA].
87. See generally James G. Hodge, Jr., The Intersection of Federal Health Information
Privacy and State Administrative Law: The Protection of Individual Health Data and Worker’s
Compensation, 51 ADMIN. L. REV. 117 (1999).
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regardless of the holder or manner of communication, are needed to complete a
national standard of health information privacy.
B.

Consenting to Uses and Disclosures of Protected Health Information

Regulating the use and disclosure of PHI is essential in assuring patients’
privacy because of the potential risk of harm from unlimited sharing of
personal medical data. Requiring informed consent for uses and disclosures
allows individuals some degree of control over their individually-identifiable
health information. HHS augments consent protections by imposing a
minimum disclosure standard that limits the amount of information that can be
shared. The standard requires that when using, disclosing or requesting PHI,
the covered entity must make reasonable efforts to limit the disclosure to the
minimum amount of information necessary to accomplish an otherwise lawful
purpose.88 Collectively, these measures can enhance patient autonomy and
promote trust in the health care system.89 The minimum disclosure standard
helps patients maintain their privacy in transactions, such as reimbursement,
where only specific health information is required and additional disclosures
could lead to harm to patients.90 Informed consent mechanisms are featured in
the health data privacy rule with mixed success. Written authorization
requiring disclosures of health data for non-health care purposes is effective in
protecting individual privacy. However, written consent requiring disclosures
for treatment, payment and health care operations fails to protect individuals
and burdens covered entities.
1.

Written Consent for Disclosure and Use for Health Care Purposes

The consent rule requires covered health care providers to obtain written
consent from individuals before using or disclosing information for treatment,
payment or health care operations. Such consent must (1) be in plain
language,91 (2) inform the individual that PHI may be used and disclosed to

88. § 164.502(b)(1).
89. See Gostin, Health Information Privacy, supra note 4, at 522. For further discussion, see
HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 22-33 (arguing that personally
identifiable health information should not be disclosed without authorization except in limited
circumstances).
90. HHS’s recent guidance has clarified a significant concern of health care providers over
the permitted uses during treatment when consulting with other physicians or medical staff. The
standard as written specifies that the minimum disclosure requirement applies for use of PHI
during treatment by health care providers, but not disclosures. This has caused confusion about
how health care providers can utilize vital health information in the course of treatment as they
work with other medical professionals. In the July, 2001 guidance, HHS explained that the
exemption for disclosures during treatment allows health care providers to share information with
other providers. See Office for Civil Rights Standards, supra note 57.
91. § 164.506(c).
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carry out those activities,92 (3) indicate that the individual can revoke the
consent in writing93 and (4) state that the individual may request that the
covered entity restrict how PHI is used or disclosed for health care purposes,
though the covered entity is not required to agree.94 Certain exceptions for
specific disclosures are discussed below.
The written consent requirement for use and disclosure of PHI in health
care activities is largely inadequate.95 Consent under these circumstances is
neither informed nor consensual. A patient may sign a consent form on his
first visit to a physician that applies to all future disclosures and uses. In such
cases, the individual will not be aware of the substance of the data protected
because he will typically not know what information is contained in his current
records, or what may be contained in his future medical records.96 At the time
of consent, he will also not be aware of the specific uses or disclosures because
the consent form need only state “treatment, payment, or health care
operations.”97 For these reasons, his execution of a written authorization prior
to treatment is uninformed. Such authorization also lacks effective consent
where the rule allows providers to condition enrollment in a plan or medical
treatment on whether the individual signs the consent.98 As a result, the patient
can be forced to consent if he wants to obtain treatment or health insurance.99
The written consent requirement also creates significant burdens for the
health care industry. While many health providers already maintain individual
informed consent as part of most health care transactions, all covered entities
will have to develop mechanisms to obtain, access and store consent forms
from every individual. Health care providers have the additional concern of
having to delay treatment because consent forms are lost or unsigned.100

92. § 164.506(c)(1)-(2). The consent may not be combined in a single document with the
notice. § 164.506(b)(3).
93. § 164.506(c)(5).
94. § 164.506(c)(4). If the covered entity does agree, the agreement is binding. See §
164.522(a) (restating the standard for an individual’s right to request restrictions of uses and
disclosures and documenting the requirements for termination of the restrictions).
95. Note that the consent requirement was not in the proposed rule.
96. See Gostin, Regulations under HIPAA, supra note 86, at 3017.
97. § 164.506(c)(1).
98. § 164.506(b)(1)-(2).
99. See HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 22.
100. See id. A further burden is placed on the practices of pharmacists. As the regulation is
currently written, pharmacists cannot use PHI to fill a prescription that was telephoned by the
individual’s doctor if the patient is a new patient to the pharmacy and has not given written
consent to the pharmacy. HHS has indicated in the guidance issued in July, 2001 that this is an
undesirable outcome and it plans to issue a proposed rule to rectify this concern. Office for Civil
Rights Standards, supra note 57. Without such a change, a sizable delay and burden on
pharmacies and patients could occur. Patients would have to visit the pharmacy to sign the
consent form, wait for the prescription to be filled and then return to pick up their prescriptions at
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Authorization for Disclosure and Use Not Related to Health Care

A different consent model for disclosures and uses of PHI unrelated to
health care is employed in the rule. Such disclosures of PHI may be made for
employment decisions or the evaluation of credit status. Prior to using or
disclosing PHI for non-health care purposes, covered entities must obtain an
authorization from the individual. The authorization, unlike the written
consent required for health care purposes, contains specific information to help
individuals decide whether to permit disclosure or use. Such authorizations
must (1) identify the information to be used or disclosed in a “specific and
meaningful fashion;”101 (2) provide the names of the persons or organizations
who will make and receive the use or disclosures;102 (3) explain the purpose for
each request;103 (4) notify the individual of his right to refuse to sign the
authorization without negative consequences to treatment or health plan
eligibility (except under specific circumstances);104 (5) be written in plain
language105 and feature an expiration date;106 and (6) explain that the
individual has a right to revoke the authorization107 at any time in writing
except regarding actions taken by the covered entity in reliance of the
authorization.108 This authorization process better protects patients’ privacy
than the written consent requirement because covered entities generally may
not condition treatment or insurance enrollment on a patient’s signature of the
authorization.109

the pharmacies, while the pharmacies would have to devise a method to store and process the
consents. See Gostin, Regulations under HIPAA, supra note 86, at 3017.
101. § 164.508(c)(1)(i).
102. § 164.508(c)(1)(ii)-(iii).
103. § 164.508(d)(1)(ii).
104. § 164.508(e)(1).
105. § 164.508(c)(2).
106. § 164.508(c)(1)(iv).
107. § 164.508(c)(1)(v)-(vi).
108. § 164.508(b)(5)(i).
109. § 164.508(b)(4). There are some limited exceptions. One is that health care providers
may condition provision of research-related treatment on authorization. §164.508(b)(4)(i).
Another is that if the covered entity is gathering individually-identifiable health information
solely for the purposes of disclosing it to a third party, such as an employer, the covered entity
may condition this care on the authorization to disclose it to the third party. § 164.508(b)(4)(iv).
Further protection is offered regarding psychotherapy notes. Authorization is always required for
use and disclosure of psychotherapy notes except in specified health care operations.
§ 164.508(a)(2).
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Making Exceptions: Balancing Communal Goods and Personal
Privacy

The privacy rule makes several exceptions to the informed consent and
authorization provisions related to the use of disclosure of PHI. These
exceptions include:
a.

Law Enforcement

A covered entity may disclose PHI to a law enforcement official without
informed consent pursuant to a court order, subpoena or administrative request,
including a civil investigative demand or an administrative subpoena.110
Judges are given no criteria from which to make their determination as they
balance individual privacy and law enforcement. In addition, a covered entity
may disclose limited information111 without prior judicial approval where: (i)
the information relates to a crime victim who is incapacitated and disclosure is
necessary and in the best interests of the individual;112 (ii) PHI is evidence of
“criminal conduct that occurred on the premises of the covered entity;”113 and
(iii) in the course of an emergency, disclosure is necessary to alert law
enforcement to the location, commission and nature of the crime, victims or
perpetrators.114
b.

Judicial and Administrative Proceedings

PHI may be disclosed in any judicial or administrative proceeding without
the person’s permission in response to an order of the court overseeing the
proceeding.115 As in the law enforcement context, judges are given no criteria
in the rule to exercise their discretion. Covered entities may also disclose
health information in response to a subpoena or discovery request if the
110. See § 164.512(f)(1). When an administrative request is utilized, the rule lays out certain
requirements: (1) the information sought must be “relevant and material to a legitimate law
enforcement inquiry;” (2) the request must be “specific and limited in scope to the extent
reasonably practicable;” and (3) de-identified information must not be able to be reasonably used.
§ 164.512(f)(1)(C).
111. § 164.512(f)(2)(i). The permitted information is name, address, date and place of birth,
social security number, blood type, type of injury, date and time of treatment and a description of
distinguishing characteristics. Id.
112. § 164.512(f)(3). The specific criteria are: (1) the law enforcement official represents that
the information is needed to determine whether a crime occurred by an individual other than the
victim and that the information will not be used against the victim; (2) the law enforcement
official represents that immediate law enforcement activities would be jeopardized by waiting for
consent; and (3) the covered entity determines that the disclosure is in the best interest of the
individual. § 164.512(f)(3)(iii). If the patient is competent and no emergency exists, the patient
must agree under the exception for the disclosure to occur. § 164.512(f)(3)(i).
113. § 164.512(f)(5).
114. § 164.512(f)(6).
115. § 164.512(e).
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requester (i) reasonably attempts to inform the patient of the disclosure;116 or
(ii) reasonably attempts to obtain a protective order to prohibit the recipients
from using or disclosing the information for purposes other than the
litigation.117 Instead of placing the burden on litigants seeking the information,
the rule requires that patients make objections to the court.
c.

Minors

Disclosures to parents of unemancipated minors are exempted from
consent requirements in multiple cases. If state law forbids or requires that
parents be informed about their children’s health conditions, the rule allows
state law to stand.118 While many states permit competent minors to receive
medical treatment for potentially stigmatizing conditions without parental
consent,119 states could pass laws requiring parents to be informed about their
child’s condition and treatment. Where no state law exists, the rule allows
parents to serve as personal representatives,120 who generally can act on behalf
of the individual121 child under some restrictions.122 The Bush Administration
has suggested that it may modify the rule to increase parental access.123

116. § 164.512(e)(1)(ii)(A). The covered entity must obtain satisfactory assurances that the
party requesting information has made a good faith attempt to provide written notice to the
individual and that the notice included sufficient information about the litigation to permit the
individual to raise an objection in the proceedings. § 164.512(e)(1)(iii)(A) & (B). The covered
entity must also be given assurances that the time for the individual to raise objections to the
court has elapsed and that any objections given were resolved in the favor of the requester.
§ 164.512(e)(1)(iii)(C).
117. § 164.512(e)(1)(ii)(B). The party requesting information must give the covered entity
satisfactory assurances that the parties have agreed to a qualified protective order or that the
requester has asked for a qualified protected order. § 164.512(e)(1)(iv). The standard defines
qualified protective order as one that prohibits the parties from using or disclosing PHI for any
purpose other than litigation or proceeding for which the information was requested and requires
the PHI’s return to the covered entity or destruction at the end of the proceeding.
§ 164.512(e)(1)(v).
118. See § 160.202 (defining “more stringent”).
119. See Gostin, Regulations under HIPAA, supra note 86, at 3017.
120. See § 164.502(g)(1).
121. § 164.502(g)(2).
122. § 164.502(g)(3). If the minor consents to the health care service, the parent agrees to
confidentiality between provider and the minor, or if the minor consents and does not wish the
parent to be the personal representative, then the parent is not considered a personal
representative. Id.
123. See Press Release, Secretary Thompson, supra note 2 (“we will make it clear through
guidelines or recommended modifications that . . . parents will have access to information about
the health and well-being of their children, including information about mental health, substance
abuse or abortion”). Id. The July, 2001 guidance indicated the Secretary is still considering such
action. See Office for Civil Rights Standards, supra note 57 (referring to statements in the section
on “Parents and Minors”).
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“Significant Others” of Adults and Emancipated Minors

Disclosures to “significant others” (meaning family, friends, caretakers or
health care surrogates) of adults and emancipated minors are narrowly
exempted. Covered entities may disclose limited health information to
“significant others” without consent if the patient is informed in advance and
has the opportunity to agree.124 The disclosed PHI must be (i) directly relevant
to the person’s involvement with the patient’s care or payment for care;125 or
(ii) used to notify that person of the patient’s location, general health condition,
or death.126 In cases of incapacitation or emergency, disclosures to “significant
others” may be made in the patient’s best interest when directly relevant to the
entity’s involvement with the individual’s care.127
e.

Public Health

The health data privacy rule broadly exempts128 disclosures of PHI for
routine public health activities.129 This includes disclosures: (i) where federal
or state law authorizes public health authorities130 to collect PHI to prevent or
control disease, injury or disability, or report child abuse or neglect; (ii) to
notify persons who may be at risk for or exposed to a communicable disease
(for instance, partner notification provisions);131 (iii) concerning adverse
events, tracks and recalls of products, and post marketing surveillance by
persons subject to the jurisdiction of the Food and Drug Administration.132
State reporting or other public health laws that offer more stringent privacy
protections are not preempted by the rule.133
f.

Health Research

Most federally-funded human subject research is currently governed by a
federal regulation known as the Common Rule,134 which does not contain
124. See 45 C.F.R. § 164.510(b)(1) & (2) (2001). Disclosure is also permitted if the covered
entity can reasonably infer from the circumstances that the patient does not object to disclosure.
See § 164.510(b)(2)(iii).
125. § 164.510(b)(1)(i).
126. § 164.510(b)(1)(ii).
127. § 164.510(b)(3). The rule allows relatives and close personal friends to perform
common care-taking duties such as picking up prescriptions, medical supplies, et cetera. Id.
128. § 164.514(b)(2) (clarifying that all of the exceptions apply to uses of PHI, as well as
disclosures in the public health exemptions section).
129. See Gostin, Regulations under HIPAA, supra note 86, at 3019.
130. Public health authority is expansively defined as a federal, tribal, state or local agency or
authority, or a person or entity with a grant of authority from or contract with the agency that is
responsible for public health matters as part of its official mandate. 45 C.F.R. § 164.501.
131. § 164.512(b)(1)(i)(ii), (iv).
132. § 164.512(b)(1)(iii), (v).
133. § 160.203(b).
134. Protection of Human Subjects, 56 Fed. Reg. 28003 (1991) (codified at 45 C.F.R. pt. 46).
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detailed privacy standards. Rather, this rule conditions institutional review
board (IRB) approval of research on whether “there are adequate provisions to
protect the privacy of subjects . . . .”135 Though the Common Rule is a helpful
guide for protecting the privacy and other ethical interests of human research
subjects, it does not apply to privately-funded research. The health data
privacy rule closes this gap between the federal and private sectors by
providing more detailed requirements than the Common Rule. A covered
entity may only use or disclose PHI for research without the person’s
permission if it obtains a waiver from an IRB or privacy board136 that finds: (i)
the use or disclosure involves no more than minimal risk; (ii) the waiver will
not adversely affect the privacy rights and welfare of the individuals; (iii) the
research could not practicably be conducted without the waiver; (iv) the
research could not be conducted without the protected health information; (v)
the privacy risks are reasonable in relation to the anticipated benefits, if any, to
individuals and the importance of the research; (vi) a plan exists to protect the
identifiable information from improper use and disclosure; (vii) a plan to
destroy the identifiers exists unless there is a health or research justification for
retaining them; and (viii) there are written assurances that the data will not be
reused or disclosed to others, except for research that would also qualify for a
waiver.137 Researchers must also show that PHI is necessary for the research,
will not be disclosed to outsiders and is sought solely to prepare for the
research.138 While certain critics are concerned about the burdens imposed by
the new requirements,139 the standard fairly ensures that there are valid
justifications for utilizing PHI for research without consent.
g.

Commercial Marketing

In contrast to some of the other exceptions, which offer either greater or
similar protections than the law currently provides, the exception for
135. Protection of Human Subjects, 45 C.F.R. § 46.111(a)(7). In the Common Rule, if
consent is required, the researcher must provide the subject with “[a] statement describing the
extent, if any, to which confidentiality of records identifying the subject will be maintained . . . .”
45 C.F.R. § 46.116(a)(5). The Common Rule also applies to research conducted in anticipation
of Food and Drug Administration approval.
136. § 164.512(i)(1)(i). The privacy board must have members with varying backgrounds,
appropriate professional competency and no conflict of interest. § 164.512(i)(1)(i)(B). At least
one member must be unaffiliated with the covered entity and research entity.
§
164.512(i)(1)(i)(B)(2). This includes relatives of individuals affiliated with the organizations. Id.
A majority of the privacy board must be present when considering a waiver, including the
unaffiliated member. § 164.512(i)(2)(iv)(B).
137. § 164.512(i)(2)(ii).
138. § 164.512(i)(1)(ii). See Mark Barnes & Sara Krauss, The Effect of HIPAA on Human
Subject Research, 10 HEALTH L. REP. 1026, 1030-31 (2001).
139. See, e.g., Barnes & Krauss, supra note 138, at 1031 (arguing that IRB’s are ill-prepared
to make the assessments now required of them by the health data privacy rule).
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commercial marketing provides for less privacy protection by condoning the
use or disclosure of PHI for commercial marketing without consent.140 PHI
may be used or disclosed without consent for marketing communications to the
individual that occur in face-to-face encounters (whether health-related or not),
concern products or services of nominal value, or concern health-related
products and services of the covered entity or a third party.141 A covered entity
may target persons based on their health status if the product or service may be
beneficial to them.142 Thus, under this exception, a non-physician salesperson
can approach individuals with potentially stigmatizing conditions (such as
HIV, pregnancy or mental illness) at their residences and inform them that he
learned of their illness without their consent and would like to sell or offer
information about a product.
4.

Principles to Guide Disclosure Exceptions

Many of these exceptions sacrifice individual autonomy regarding personal
privacy interests for the sake of communal goods and commercial interests. In
certain contexts, such trade-offs may be appropriate, especially when HHS’s
broader goal of enhancing the health of the population is achieved. Yet, as
with many existing health information privacy laws, some disclosure
exceptions to an informed consent requirement lack credibility and may be
ethically unsound. Exceptions in a health information privacy statute must be
ethically justified to enhance individual trust in the health care system and
improve health outcomes, consistent with the following principles:
a.

Further Health Care Purposes

While most exchanges of health data in the electronic health information
infrastructure should be made only after an individual’s consent, some
disclosures may be justifiable without informed consent when made for healthrelated purposes. Disallowing such disclosures could negate advancements in
individual or populational health outcomes by denying access to health data to
persons with a legitimate need to know. Public health and research activities
clearly advance this aim, as do limited disclosures to “significant others” in the
case of medical emergencies or basic care-taking activities (such as picking up
prescriptions or X-rays). In contrast, exemptions for law enforcement, judicial
and administrative proceedings and commercial marketing do not serve to
improve individual and public health outcomes.

140. Robert Gellman, Analysis of the Marketing Provisions of the HIPAA Privacy Rules,
available at http://www.hipaadvisory.com/action/privacy/marketing.htm (last modified Jan.
2001).
141. § 164.514(e)(2).
142. § 164.514(e)(3)(ii)(A).
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Operate in the Individual’s Best Interest

Ethical principles support non-consensual disclosures made to directly
benefit the subject of PHI through the delivery of clinical care or the provision
of other health services (such as the disclosure exception for “significant
others” of adults or emancipated minors whose best interests are explicitly
considered by the covered entity in case of emergency or the patient’s
incapacity). Of less benefit is the ability of parents to obtain PHI of minors
regarding treatment for potentially stigmatizing conditions such as pregnancy
or sexually-transmitted diseases where state laws permit such disclosures.
Minors fearing punishment may avoid treatment to the detriment of their
individual well-being. Avoiding treatment might also result from exceptions
for law enforcement and judicial and administrative proceedings, where PHI
can ultimately be used to punish individuals (such as for criminal actions) or
reduce judicial remedies (for example, in workers’ compensation cases to show
a pre-disposition to a relevant injury).143
c.

Promote Communal Health While Minimally Threatening Individual
Privacy

Where the benefits of public health and research relate to society, as well
as individuals, non-consensual disclosures of PHI for such communal, healthrelated goods (such as public health and health research) are justified. Public
health practice has traditionally relied on these disclosures as authorized
through federal, state and local laws. Human research (in some cases) may
necessitate the need to use PHI without informed consent. Though the
autonomous interests of the individual are infringed through these disclosures,
the utilitarian premise that individuals should contribute to these greater goods
in society sustains these types of disclosures.
d.

Disregard Commercial Interests of Health Care Industry

Like public health authorities and researchers, private industry (health
insurers, pharmaceutical companies and medical products providers, for
instance) may claim a need for PHI to provide products, services or knowledge
that improve individual and communal health. In some cases, these claims are
legitimate. However, where access to PHI is undergirded by profit-oriented
goals of recipients in the private sector (as contrasted with the communityoriented goals of government or academic researchers), the claim for nonconsensual access to PHI is unjustified. People may choose to participate in
private sector research or marketing campaigns, but should not have to. The
commercial marketing exception unacceptably permits broad disclosures based
on a pure profit motive before individuals have a chance to object.

143. See Hodge, supra note 87, at 120.
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C. Privacy and Security Policies for Covered Entities
In addition to an individual’s right to control uses and disclosures, the
development of privacy and security policies for covered entities is important
to prevent privacy breaches and maintain consumers’ trust in the health care
system. Without such policies, accidental disclosures from sloppy record
keeping and purposeful disclosures by and to unscrupulous parties may
proliferate.144 Addressing these concerns, the health data privacy rule
mandates that covered entities develop privacy and security policies while
maintaining the flexibility necessary for the large variety of participants
covered by the rule.145 Covered entities must implement policies that
reasonably protect from any “intentional or unintentional use or disclosure in
violation of the standards, implementation specifications or other
requirements.”146 Covered entities must not only guard against a deliberate
attempt to use protected information, but also must endeavor to prevent
accidental uses and disclosures. Procedures must be developed to allow for
complaints about the policies or the covered entities’ compliance with the
policies.147 Staff members who violate privacy policies may be sanctioned.148
A covered entity may not require an individual to waive these rights in
order to receive care, enroll in a health plan or obtain benefits.149 However,
covered entities are not mandated to create a formal appeals process or a form
of “due process.”150 When violations occur, the covered entity must mitigate
“to the extent practicable” any harmful effect known to result from the
infraction.151
144. For more on the impact on personal privacy from security policies, see HEALTH
PRIVACY PROJECT, BEST PRINCIPLES, supra note 72, at 20-22.
145. Specific concerns calling for flexibility include that the nature of the health information
held by covered entities may differ, smaller organizations may be burdened greatly by
requirements more appropriate for larger firms and the swift changes in technology may require a
fast process to update the privacy and security policies. See Gostin, Health Information Privacy,
supra note 4, at 526.
146. 45 C.F.R. § 164.530(c)(2) (2001). Group health plans that provide benefits only through
a health maintenance organization (HMO) or an issuer and that do not create, receive or maintain
PHI are not subject to any of the requirements under this section except documentation of their
plan materials. § 164.530(k). The issuers and HMOs must still follow all of the elements of the
privacy and security policy mandates. See Standards for Privacy of Individually Identifiable
Health Information, 65 Fed. Reg. 82,563-64 (Dec. 28, 2000).
147. § 164.530(d). Covered entities are also forbidden from taking any “intimidating or
retaliatory acts” against an individual involved in the privacy policy process, including those
filing a complaint. § 164.530(g).
148. § 164.530(e)(1).
149. § 164.530(h).
150. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,562 (Dec. 28, 2000).
151. § 164.530(f). Balancing the protections for individuals requires flexibility for
businesses. Every covered entity is not compelled to develop the same privacy and security
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D. Fair Information Practices
Persons and entities maintaining PHI must adhere to a range of fair
information practices that allow individuals to make informed choices about
the delivery and financing of their health care. The health data privacy rule
proscribes several fair information practices for health consumers.
1.

Notice

Health care consumers have the right to adequate notice of the uses and
disclosures of PHI that may be made by the covered entity.152 Individuals are
also entitled to know their rights and the covered entity’s legal duties regarding
the new privacy and security policies and fair information practices
requirements.153 The notice must be in plain language to prevent covered
entities from employing legal language that may confuse individuals.154 The
type of notice required is determined by the nature of the covered entity.155
Several consumer safeguards apply to covered entities that pursue electronic
notice.156
policies. Instead, the policies must be “reasonably designed, taking into account the size of and
the type of activities that relate to PHI undertaken by the covered entity.” § 164.530(i)(1). This
generalized description of the requirement allows small businesses to develop plans that reflect
the nature and size of their enterprise without burdening them more than necessary. Small
businesses might still find some of the requirements overly burdensome. For example, a sole
practitioner largely relying on paper medical records might be challenged by the need to prevent
accidental disclosure from a misplaced record. As the health data privacy rule mandates that
covered entities’ privacy policies “promptly” comply with changes in law, further difficulties can
arise to small businesses with limited resources to monitor legal developments and implement
swift changes. § 164.530(i)(3). See also Gostin, Regulations under HIPAA, supra note 86, at
3018.
152. § 164.520(a)(1). For more on the necessity of providing such notice, see Gostin, Health
Information Privacy, supra note 4, at 522-24; HEALTH PRIVACY PROJECT, BEST PRINCIPLES,
supra note 72, at 19-20.
153. § 164.520(a)(1). The notice must include information about how individuals may
complain about potential misuses or violations to the covered entity and the Secretary of HHS or
contact the covered entity with questions. § 164.520(b)(1)(vi).
154. § 164.520(b)(1).
155. § 162.520(c)(1), (2). Health plans must provide notice to covered individuals by the
compliance date of the regulation. New enrollees must get the notice at the time of enrollment.
At least once every three years, the health plan must notify enrollees in the plan that the notice is
available and the methods by which they can obtain it. § 164.520(c)(1). In contrast, health care
providers have to provide the notice upon the first service delivery after the compliance date. §
164.520(c)(2).
156. An individual must agree to obtain the notice via e-mail. A paper copy must be provided
if the covered entity knows that the e-mail transmission failed. § 164.520(c)(3)(ii). Health care
providers must give electronic notice automatically and simultaneously when their first service
delivery is electronic. § 164.520(c)(3)(iii). If a covered entity maintains a web site that offers
information about its benefits and services, it must also prominently post its notice on the web
site as well as make it available electronically. § 164.520(c)(3)(i).
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Access to Protected Health Information

The new regulation offers individuals a broad opportunity to access their
PHI.157 Access rights include an on-site inspection of the records and the
provision of copies.158 Covered entities must act within thirty days upon the
request.159 If the individual agrees in advance, the covered entity may provide
a summary of the PHI instead of the actual documents.160 The standard does
permit narrow reasons that cannot be reviewed for denial regarding requests
for psychotherapy notes; information likely to be used in a civil, criminal or
administrative proceeding; and requests by inmates to their correctional facility
or health care provider that might threaten the health or safety of the individual
or others.161 Also, in limited circumstances,162 a covered entity may deny
access as long as the individual may request a review of the grounds for
denial.163 If the covered entity decides to deny access to the individual of any
part of the PHI, the rule ensures a fair and informed process.164

157. § 164.524 (2001). The covered entity may require the request be in writing. §
164.524(b)(1). For more on the significance of the individual’s ability to access their personal
medical data, see Gostin, Health Information Privacy, supra note 4, at 524; HEALTH PRIVACY
PROJECT, BEST PRINCIPLES, supra note 72, at 18-19.
158. § 164.524(c)(1).
159. Id. § 164.524(b)(2)(i). Sixty days is allowed if the information is held off-site. §
164.524(b)(2)(ii). Delay is also allowed if the covered entity informs the individual in writing of
the reasons it requires more time and when the request will be granted. § 164.524(b)(2)(iii).
160. § 164.524(c)(2)(ii).
161. § 164.524(a)(1), (2). Information obtained from another based on a promise of
confidentiality and that would likely reveal the identity of the source may be denied without
review. § 164.524(a)(2)(v). Also, health care providers may temporarily deny access during
research based on an individual’s care if the individual has consented to the research, and the
denial of access occurs during research. § 164.524(a)(2)(iii).
162. These situations include where a licensed health care professional determines that access
will endanger the life or physical safety of the individual or another person. § 164.524(c)(3).
163. Id. This provision specifically covers determinations that references to another person
will endanger that other individual, or that, if a personal representative is making the request,
substantial harm will come to the individual or another person. § 164.524(c)(3).
164. The denial must be in writing and in plain language. It must explain the reasons for the
denial, any rights for review over the decision and methods of complaint to the covered entity. §
164.524(d)(2). Access should be granted to any information that does not meet the specific
grounds for denial. § 164.524(d)(1). If a review of the denial is warranted, it is conducted by a
licensed health care professional who is designated by the covered entity but is not directly
involved in the decision to deny access. § 164.524(d)(4).
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Amend Protected Health Information

Individuals may amend their PHI if they note inaccuracies or missing
information.165 The covered entity must act within sixty days on a request to
amend.166 If the covered entity agrees to the amendment, it must (a) identify
the records that are affected by the amendment, (b) append or provide a link to
the amendment167 and (c) inform the individual of the amendment.168
Additional covered entities who possess or receive the data must amend their
records with the corrected information about the relevant individual.169 As
with access rights, covered entities may deny amendments in certain
circumstances, including upon a determination that the record is “accurate and
complete.”170 The entity must give written notice to the individual upon denial
of a request for an amendment.171 Should the individual disagree in writing,172
the covered entity can respond with a written rebuttal.173 Yet, unlike disputes
over denial to access, there is no final review to clarify which party, the
individual or the covered entity, is correct.

165. § 164.526(a)(1). See Gostin, Health Information Privacy, supra note 4, at 524 and
HEALTH PRIVACY PROJECT, BEST PRINCIPLES, supra note 72, at 18-19, for more on the
significance of this right.
166. § 164.526(b)(2)(i). An extension of thirty days is possible if the covered entity explains
the reasons for delay and the date on which it will respond to the request in writing to the
individual. § 164.526(b)(2)(ii).
167. § 164.526(c)(1), (2).
168. § 164.526(c)(2), (3). It must also notify persons or entities (1) identified by the
individual as needing the amended information; or (2) known by the covered entity to have PHI
about the individual and who may rely on the information to the detriment of the individual. Id.
169. § 164.526(e).
170. § 164.526(a)(2)(iv). Other grounds for denial are: (1) if the covered entity did not create
the information or record, it may deny the request unless the individual reasonably shows that the
originator of the information is no longer available to address the amendment request and (2) if
the individual could not access the record because of restrictions laid out in § 164.524 (see Part
II.D.1 above), the covered entity would have grounds to deny the amendment. § 164.526(a)(2)(i),
(iii).
171. § 164.526(d)(1). It must be in plain language and explain the reasons for the denial, any
rights for review over the decision and methods of complaint to the covered entity. §
164.526(d)(1)(i)-(iv).
172. § 164.526(d)(2).
173. § 164.526(d)(3). The individual must be provided with a copy of the rebuttal. The
written statement and rebuttal must then be appended or linked to the appropriate records by the
covered entity (§ 164.526(d)(4)) and included, when relevant, in any future disclosures. §
164.526(d)(5)(i). If the individual has not submitted a written statement of disagreement, then the
request for amendment and covered entity’s denial must be included if the individual has
requested such disclosure. § 164.526(d)(5)(ii).
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Request an Accounting of Disclosures

Patients have a limited right to receive an accounting of disclosures of their
PHI (other than for disclosures related to treatment, payment and health care
operations, among other exceptions174) over the six year period prior to the
request.175 The accounting includes the name of the person or entity who
received the information (and their address if known), the date of the
disclosure, a brief description of the information disclosed and a brief
explanation of the reasons for disclosure if not authorized by the patient.176
E.

The Effects of Pre-emption

Under HIPAA, HHS cannot preempt state health information privacy laws
that are more protective of patients than the national rule.177 For this reason,
the rule sets a federal “floor” of protections. Some states may offer more
protections through, for example, “super-confidentiality” laws for genetic,
mental health or HIV/AIDS information.178 This multi-level approach to
protecting privacy has at least two disadvantages: (1) it unfairly allows
individuals in some states to benefit from greater privacy protections than in
other states; and (2) where most electronic health data is exchanged across
state boundaries, covered entities (specifically larger health providers, plans
and clearinghouses) must adhere to both national and regional privacy
standards. This likely results in higher costs than would occur if a uniform
national standard was in place.179
III. CONCLUSION
The systematic electronic collection, use and disclosure of individuallyidentifiable health information are essential to achieving several important
communal goals. Public health authorities and health researchers require such
data to perform accurate, beneficial studies and to shape effective interventions
and treatments. The exchange of electronic data can improve clinical
outcomes, prevent fraud and abuse, and help consumers make informed
choices about their health care. With these positive aspects, however, come
significant threats to individual privacy. People are concerned about

174. These include: national security and intelligence purposes; correctional institutions; and
health oversight agencies or law enforcement officials who document that the agency’s officials
would be impeded if the accounting revealed the disclosure. § 164.528(a)(1), (2).
175. § 164.528(a)(1).
176. § 164.528(b)(2)(i)-(iv).
177. § 160.203(b). State laws are also not pre-empted if they promote certain goods such as
public health, efficacy in payment of health care, fraud prevention and audits and program
monitoring. § 160.203(a)(1)(i), (iv), (d).
178. See Gostin, Regulations under HIPAA, supra note 86, at 3020.
179. See id.
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discrimination and autonomy violations that follow unwarranted disclosures to
health insurers, employers and governmental agencies.
Through its health information privacy rule, HHS seeks to provide a
national standard that balances individual interests in health information
privacy with society’s interests in accomplishing various communal goals.
The rule provides expansive, new protections for health data privacy and
security. In many ways it improves existing privacy protections by creating a
more fair and even field in which information can be responsibly exchanged.
Unfortunately, the rule fails to provide a sufficient floor of protection for the
use and disclosure of all health information. Limited by Congressional
authorization under HIPAA, HHS at times trades personal privacy for public
(such as the public health exception) and non-public goods (such as the
commercial marketing exception). Reaching a proper balance between
individual and communal uses of health data may require additional
authorization from Congress, or alternatively, new federal legislation. For
now, the rule represents a new standard in an age of increasing threats to
individual interests in protecting the privacy of their health data.
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